Increased ACSL4 expression is observed in tumors, particularly triple-negative breast cancer, where higher ACSL4 levels may enhance sensitivity to radiotherapy and chemotherapy [31]. This evidence concerns the gene ACSL4 and triple-negative breast carcinoma.